Osimertinib for Front-Line Treatment of Locally Advanced or Metastatic EGFR-Mutant NSCLC Patients: Efficacy, Acquired Resistance and Perspectives for Subsequent Treatments

por Denis, Marc G, Bennouna, Jaafar
Publicado 2020

Molecular minimal residual disease in resected non-small cell lung cancer (NSCLC): results of specifically designed interventional clinical trials eagerly awaited

por Denis, Marc G., Herbreteau, Guillaume, Pons-Tostivint, Elvire
Publicado 2023

Detection of EGFR Mutations in the Plasma of Patients with Lung Adenocarcinoma for Real-Time Monitoring of Therapeutic Response to Tyrosine Kinase Inhibitors?

por Marcq, Marie, Vallée, Audrey, Bizieux, Acya, Denis, Marc G.
Publicado 2014

Guide to detecting epidermal growth factor receptor (EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancer

por Normanno, Nicola, Denis, Marc G., Thress, Kenneth S., Ratcliffe, Marianne, Reck, Martin
Publicado 2016

Prospective evaluation of two screening methods for molecular testing of metastatic melanoma: Diagnostic performance of BRAF V600E immunohistochemistry and of a NRAS-BRAF fully aut...

por Vallée, Audrey, Denis-Musquer, Marie, Herbreteau, Guillaume, Théoleyre, Sandrine, Bossard, Céline, Denis, Marc G.
Publicado 2019

Detection of EGFR gene mutations in non-small cell lung cancer: Lessons from a single-institution routine analysis of 1,403 tumor samples

por VALLEE, AUDREY, SAGAN, CHRISTINE, LE LOUPP, ANNE-GAELLE, BACH, KALYANE, DEJOIE, THOMAS, DENIS, MARC G.
Publicado 201

High efficacy of alectinib in a patient with advanced lung adenocarcinoma with 2 rare ALK fusion sites: a case report

por Li, Yan, Duan, Peng, Guan, Yan, Chen, Qing, Grenda, Anna, Christopoulos, Petros, Denis, Marc G., Guo, Qisen
Publicado 2022

Quantitative monitoring of circulating tumor DNA predicts response of cutaneous metastatic melanoma to anti-PD1 immunotherapy

por Herbreteau, Guillaume, Vallée, Audrey, Knol, Anne-Chantal, Théoleyre, Sandrine, Quéreux, Gaelle, Varey, Emilie, Khammari, Amir, Dréno, Brigitte, Denis, Marc G.
Publicado 2018

Circulating Tumor DNA Early Kinetics Predict Response of Metastatic Melanoma to Anti-PD1 Immunotherapy: Validation Study

por Herbreteau, Guillaume, Vallée, Audrey, Knol, Anne-Chantal, Théoleyre, Sandrine, Quéreux, Gaëlle, Varey, Emilie, Khammari, Amir, Dréno, Brigitte, Denis, Marc G.
Publicado 2021

Activation of the prostaglandin D2 metabolic pathway in Crohn’s disease: involvement of the enteric nervous system

por Le Loupp, Anne-Gaelle, Bach-Ngohou, Kalyane, Bourreille, Arnaud, Boudin, Hélène, Rolli-Derkinderen, Malvyne, Denis, Marc G., Neunlist, Michel, Masson, Damien
Publicado 2015

Efficient treatment of a metastatic melanoma patient with a combination of BRAF and MEK inhibitors based on circulating tumor DNA analysis: a case report

por Quéreux, Gaelle, Herbreteau, Guillaume, Knol, Anne-Chantal, Vallée, Audrey, Khammari, Amir, Théoleyre, Sandrine, Saint-Jean, Mélanie, Dréno, Brigitte, Denis, Marc G.
Publicado 2017

Circulating Tumour DNA Is an Independent Prognostic Biomarker for Survival in Metastatic BRAF or NRAS-Mutated Melanoma Patients

por Herbreteau, Guillaume, Vallée, Audrey, Knol, Anne-Chantal, Théoleyre, Sandrine, Quéreux, Gaelle, Frénard, Cécile, Varey, Emilie, Hofman, Paul, Khammari, Amir, Dréno, Brigitte, Denis, Marc G.
Publicado 2020

Detection of BRAF V600 Mutations in Melanoma: Evaluation of Concordance between the Cobas® 4800 BRAF V600 Mutation Test and the Methods Used in French National Cancer Institute (IN...

por Mourah, Samia, Denis, Marc G., Narducci, Fabienne Escande, Solassol, Jérôme, Merlin, Jean-Louis, Sabourin, Jean-Christophe, Scoazec, Jean-Yves, Ouafik, L’Houcine, Emile, Jean-François, Heller, Remy, Souvignet, Claude, Bergougnoux, Loïc, Merlio, Jean-Philippe
Publicado 2015

Potential treatment strategy for the rare osimertinib resistant mutation EGFR L718Q

por Song, Yang, Jia, Ziqi, Wang, Yadong, Wang, Yanyu, Liu, Peng, Zhang, Shuyang, Bing, Zhongxing, Cao, Lei, Cao, Zhili, Rossi, Elisabetta, Zamarchi, Rita, Denis, Marc G., Camps, Carlos, Fernandez-Diaz, Amaya B., Liang, Naixin, Li, Shanqing
Publicado 2020

Concomitant mutation status of ALK-rearranged non-small cell lung cancers and its prognostic impact on patients treated with crizotinib

por Li, Jingjing, Zhang, Bin, Zhang, Yu, Xu, Feng, Zhang, Zhenfa, Shao, Lin, Yan, Chunhe, Ulivi, Paola, Denis, Marc G., Christopoulos, Petros, Thomas de Montpréville, Vincent, Bernicker, Eric H., van der Wekken, Anthonie J., Wang, Changli, Yue, Dongsheng
Publicado 2021

Metastatic pulmonary carcinoids with EML4-ALK fusion response to ALK inhibitors: two case reports and review of literature

por Lei, Xi, Zhu, Shuai, Ren, Dian, Ren, Fan, Li, Tong, Zhou, Ning, Li, Shuo, Shi, Tao, Zu, Lingling, Song, Zuoqing, Chalubinska-Fendler, Justyna, Denis, Marc G., Bernicker, Eric H., Thomas de Montpréville, Vincent, Jiang, Richeng, Xu, Song
Publicado 2022

Circulating Tumor DNA as a Prognostic Determinant in Small Cell Lung Cancer Patients Receiving Atezolizumab

por Herbreteau, Guillaume, Langlais, Alexandra, Greillier, Laurent, Audigier-Valette, Clarisse, Uwer, Lionel, Hureaux, José, Moro-Sibilot, Denis, Guisier, Florian, Carmier, Delphine, Madelaine, Jeannick, Otto, Josiane, Souquet, Pierre-Jean, Gounant, Valérie, Merle, Patrick, Molinier, Olivier, Renault, Aldo, Rabeau, Audrey, Morin, Franck, Denis, Marc G, Pujol, Jean-Louis
Publicado 2020

Detection of ALK fusion transcripts in plasma of non-small cell lung cancer patients using a novel RT-PCR based assay

por Heeke, Simon, Benzaquen, Jonathan, Vallee, Audrey, Allegra, Maryline, Mazieres, Julien, Fayada, Julien, Rajamani, Jaya, Lee, Michael, Ordinario, Ellen, Tiotiu, Angelica, Cadranel, Jacques, Poudenx, Michel, Moro-Sibilot, Denis, Barlesi, Fabrice, Gervais, Radj, Thariat, Juliette, Tanga, Virginie, Boutros, Jacques, Ilié, Marius, Hofman, Véronique, Marquette, Charles-Hugo, Denis, Marc G., Hofman, Paul
Publicado 2021